MELA Sciences, Inc. is a medical device company engaged in designing and developing software-driven technology for the early detection of skin cancer. The Company is focused on the commercialization of its product, the MelaFind System (MelaFind), as well as the further design and development of this technology. MelaFind is a non-invasive, point-of-care (in the doctor's office) instrument to aid in the detection of melanoma. The System features a hand-held component that emits light of multiple wavelengths to capture digital data from clinically atypical pigmented skin lesions. The data are then analyzed utilizing sophisticated algorithms, trained by the Company's database of melanomas and benign lesions. This result provides information to assist in the management of the patient's disease, including information useful in the dermatologist's decision on whether to biopsy the lesion.